Faez Ayoob, MD
Vascular Surgery · Phoenix, AZNPI 1447505458
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,381 of the $15,990 with a category attached, or 64.9%. 12 manufacturers reported payments, led by Boston Scientific at 30.8% of the total. Reporting peaked in 2023 at $7,798 and has fallen 62.4% since, to $2,933 in 2025.
Across 91 payments — averaging $175.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Penumbra, Inc.$4K
- Medtronic$4K
- W. L. Gore & Associates, Inc.$2K
- Endologix LLC$1K
- Surmodics, Inc.$85
- plus $278 from 6 others
Across 1 payment — averaging $625.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspiremd Ltd$625
What the payments were for
- Travel & lodging$10,38165%
- Food & beverage$5,41734%
- Education$1911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $4,929 |
| Penumbra, Inc. | 14 | $4,013 |
| Medtronic(2 entities) | 22 | $3,506 |
| W. L. Gore & Associates, Inc. | 14 | $1,988 |
| Endologix LLC | 6 | $1,191 |
| Surmodics, Inc. | 5 | $85 |
| Silk Road Medical, Inc. | 1 | $80 |
| Contego Medical, Inc | 1 | $69 |
| Lemaitre Vascular, Inc. | 3 | $56 |
| Innovation Technologies Inc | 1 | $43 |
| Thrombolex, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,990 in reported general payments places this provider in the 70th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 79 | $1,849 |
| Rosuvastatin Calcium | 16 | $502 |
| ClopidogrelClopidogrel Bisulfate | 66 | $366 |
| Gabapentin | 16 | $149 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Phoenix
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Martin ZomayaPhoenix$139K
- Curtis EricksonPhoenix$44K
- Samuel MoneyPhoenix$15K
- Wes ArleinPhoenix$12K
- Dawn OlsenPhoenix$12K
- Joseph HesselPhoenix$11K
- Julio Rodriguez LopezPhoenix$10K
- Venkatesh RamaiahScottsdale$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.